BioSpace News Archive

Lystek’s Commercial Scale, Containerized Mobile THP Units Ready to Serve the Needs of Biosolids Processing Sector

Attention: Environmental, agricultural, municipal, recycling & waste management reporters/editors

March 8, 2019
·
3 min read
Business

Neos Therapeutics to Host Fourth Quarter and Year-End 2018 Financial and Operating Results Conference Call on March 14th, 2019

Neos Therapeutics, Inc. today announced that it will report its fourth quarter and year-end 2018 financial results prior to the opening of U.S. financial markets on Thursday, March 14, 2019.

March 8, 2019
·
1 min read
Deals

Auris Medical to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on Thursday, March 14, 2019

Auris Medical Holding AG announced that it will provide a business update and report its financial results for the fourth quarter and full year 2018 on Thursday, March 14, 2019.

March 8, 2019
·
1 min read
Business

CRF Bracket Welcomes Susie Robinson as Chief People Officer

Strategic Senior Appointment Spearheads Compelling Work Culture for Continued Success

March 8, 2019
·
2 min read
Policy

Eisai’s Marketing Authorization Application for Potential Insomnia Disorder Treatment Lemborexant Submitted in Japan

Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for lemborexant, an investigational agent for sleep-wake regulation, seeking approval for use in the treatment of insomnia disorder.

March 8, 2019
·
11 min read
BioCapital

SCRS Announces the Launch of New and Improved Website

The Society for Clinical Research Sites is pleased to announce the launch of our new website at MySCRS.org.

March 8, 2019
·
1 min read
EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES

Evotec AG announced that its management will be presenting at and attending the following upcoming conferences:

March 8, 2019
·
2 min read
Potential New Treatment for Heart Attack

Prospective drug found by testing in human heart muscle grown from stem cells

March 8, 2019
·
8 min read
Business

Oxurion NV Business Update – FY 2018

Significant Progress with Novel Diabetic Eye Disease Portfolio

March 8, 2019
·
17 min read
MorphoSys Provides Updates on L-MIND and B-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL

MorphoSys AG provided updates on L-MIND and B-MIND, its two ongoing clinical trials of the investigational Fc- enhanced anti-CD19 antibody MOR208 in patients with relapsed or refractory diffuse large B cell lymphoma, who are not eligible for high-dose chemotherapy and autologous stem cell transplantation.

March 8, 2019
·
8 min read